Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
K-321 Eye Drops After Descemetorhexis in FECD
NCT04250207Phase 2Completed
- Start
- Jun 2020
- Primary completion
- Sep 2021
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of ripasudil in Fuchs endothelial corneal dystrophy (FECD). Started Jun 2020; status: completed.
02
Drugs
ripasudil
03
Conditions
Fuchs endothelial corneal dystrophy (FECD)
Beyond the preview
Go deeper on NCT04250207.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04250207.